SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of KemPharm, Inc. and Advises Investors with Losses to
Contact the Firm
Goldberg Law PC announces that it is investigating KemPharm, Inc. (“KemPharm” or the “Company”) (Nasdaq: KMPH)
concerning possible violations of federal securities laws.
If you purchased or otherwise acquired KemPharm shares and would like more information regarding the investigation, we encourage
you to click here, or contact Michael Goldberg or
Brian Schall, of Goldberg Law PC, 1999 Avenue of the Stars Suite 1100,
Los Angeles, CA 90067, at 800-977-7401, to discuss your rights without cost to you. You can also reach us through the firm’s
website at http://www.Goldberglawpc.com, or by email at info@goldberglawpc.com.
KemPharm issued a New Drug Application to the U.S. Food and Drug Administration ("FDA") for their Apadaz product, which was to
be marketed as an "abuse-deterrent" opioid with less of an addictive effect than competitor products. On May 5, 2016, KemPharm
disclosed that the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory
Committee of the FDA had consulted and voted against using an abuse-deterrent label for Apadaz. The FDA attributed the vote to an
issue with the study design of Apadaz making it difficult to use in determining the abuse-deterrent effect of the drug.
When this information was revealed to the investing public, the value of KemPharm declined, causing investors severe harm.
If you have any questions concerning your legal rights, please immediately contact Goldberg Law PC at 800-977-7401, or visit our
website at http://www.Goldberglawpc.com, or email us at info@goldberglawpc.com.
Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights
litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Goldberg Law PC, Los Angeles
Michael Goldberg, Esq., 800-977-7401
Brian Schall, Esq., 800-977-7401
info@goldberglawpc.com
http://www.Goldberglawpc.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170203005761/en/